PTC Therapeutics, Inc. (PTCT)
69.05
-0.25
(-0.36%)
USD |
NASDAQ |
Sep 08, 11:13
PTC Therapeutics Cash and Short Term Investments (Quarterly) : 2.229B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.229B |
| March 31, 2026 | 1.892B |
| December 31, 2025 | 1.945B |
| September 30, 2025 | 1.688B |
| June 30, 2025 | 1.989B |
| March 31, 2025 | 2.027B |
| December 31, 2024 | 1.140B |
| September 30, 2024 | 1.013B |
| June 30, 2024 | 1.093B |
| March 31, 2024 | 884.81M |
| December 31, 2023 | 876.74M |
| September 30, 2023 | 294.81M |
| June 30, 2023 | 337.94M |
| March 31, 2023 | 336.30M |
| December 31, 2022 | 410.70M |
| September 30, 2022 | 288.43M |
| June 30, 2022 | 505.54M |
| March 31, 2022 | 587.79M |
| December 31, 2021 | 773.38M |
| September 30, 2021 | 867.94M |
| June 30, 2021 | 947.08M |
| March 31, 2021 | 988.41M |
| December 31, 2020 | 1.104B |
| September 30, 2020 | 1.141B |
| June 30, 2020 | 498.89M |
| Date | Value |
|---|---|
| March 31, 2020 | 595.86M |
| December 31, 2019 | 686.56M |
| September 30, 2019 | 708.65M |
| June 30, 2019 | 363.54M |
| March 31, 2019 | 407.16M |
| December 31, 2018 | 227.59M |
| September 30, 2018 | 249.40M |
| June 30, 2018 | 296.11M |
| March 31, 2018 | 178.27M |
| December 31, 2017 | 191.25M |
| September 30, 2017 | 169.31M |
| June 30, 2017 | 181.07M |
| March 31, 2017 | 202.58M |
| December 31, 2016 | 231.67M |
| September 30, 2016 | 248.34M |
| June 30, 2016 | 272.89M |
| March 31, 2016 | 298.71M |
| December 31, 2015 | 338.92M |
| September 30, 2015 | 371.52M |
| June 30, 2015 | 255.22M |
| March 31, 2015 | 280.47M |
| December 31, 2014 | 315.24M |
| September 30, 2014 | 209.39M |
| June 30, 2014 | 226.86M |
| March 31, 2014 | 246.58M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen, Inc. | 1.285B |
| BioMarin Pharmaceutical, Inc. | 874.00M |
| Arcturus Therapeutics Holdings, Inc. | 191.48M |
| Spruce Biosciences, Inc. | 96.30M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |